Location History:
- Andhra Pradesh, IN (2012)
- Vijayawada, IN (2012)
Company Filing History:
Years Active: 2012
Title: Innovations in Cancer Treatment by Sengupta Krishanu
Introduction
Sengupta Krishanu is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer drugs. With a total of two patents to his name, his work focuses on innovative solutions for treating various types of cancer.
Latest Patents
Krishanu's latest patents include groundbreaking formulations for anti-cancer drugs aimed at treating metastatic malignant melanoma and other cancers. The first patent discloses triazene analogs of specific general formulas, along with their tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, and pharmaceutically acceptable salts. This invention outlines a process for preparing these triazene analogs and their compositions, which are crucial for combating cancers such as lymphomas, sarcomas, carcinomas, and gliomas. The second patent focuses on selenopheno triazene analogs, which are also designed for the treatment of metastatic malignant melanoma and other cancers. These compounds have the potential to address a wide range of cancers, including breast cancer, prostate cancer, lung cancer, and more.
Career Highlights
Sengupta Krishanu is currently associated with Kasina Laila Innova Pharmaceuticals Private Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for serious health conditions, particularly cancer.
Collaborations
Throughout his career, Krishanu has collaborated with notable colleagues such as Ganga Raju Gokaraju and Sudhakar Kasina. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Sengupta Krishanu's contributions to cancer treatment through his innovative patents highlight the importance of research and development in pharmaceuticals. His work not only showcases his expertise but also offers hope for improved treatment options for patients battling cancer.